Literature DB >> 28624099

Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention.

Farzad Masoudkabir1, Nizal Sarrafzadegan2, Carolyn Gotay3, Andrew Ignaszewski4, Andrew D Krahn4, Margot K Davis4, Christopher Franco4, Arya Mani5.   

Abstract

Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28624099      PMCID: PMC6207942          DOI: 10.1016/j.atherosclerosis.2017.06.001

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  157 in total

1.  Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells.

Authors:  Dong Kun Lee; R Nathan Grantham; Aaron L Trachte; John D Mannion; Colleen L Wilson
Journal:  Biochem Biophys Res Commun       Date:  2006-06-22       Impact factor: 3.575

2.  Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis.

Authors:  Xiaowen Hou; Xin Chen; Jingpu Shi
Journal:  Gene       Date:  2015-03-31       Impact factor: 3.688

Review 3.  Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery.

Authors:  Ekaterina A Ivanova; Alessandro Parolari; Veronika Myasoedova; Alexandra A Melnichenko; Yuri V Bobryshev; Alexander N Orekhov
Journal:  J Cardiol       Date:  2015-06-10       Impact factor: 3.159

4.  Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.

Authors:  C Prontera; B Mariani; C Rossi; A Poggi; D Rotilio
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

5.  Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis.

Authors:  Amit Kumar; Pradeep Kumar; Manya Prasad; Ram Sagar; Arun Kumar Yadav; Awadh Kishor Pandit; Vidishaa Prasad Jali; Abhishek Pathak
Journal:  Neurol Res       Date:  2015-01-16       Impact factor: 2.448

6.  LRP6 mutation in a family with early coronary disease and metabolic risk factors.

Authors:  Arya Mani; Jayaram Radhakrishnan; He Wang; Alaleh Mani; Mohammad-Ali Mani; Carol Nelson-Williams; Khary S Carew; Shrikant Mane; Hossein Najmabadi; Dan Wu; Richard P Lifton
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

7.  LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution.

Authors:  Yonghe Li; Wenyan Lu; Xi He; Alan L Schwartz; Guojun Bu
Journal:  Oncogene       Date:  2004-12-02       Impact factor: 9.867

8.  Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase.

Authors:  Masaru Saitoh; Kaoru Nagai; Kazuhiko Nakagawa; Takehira Yamamura; Satoshi Yamamoto; Tomoyuki Nishizaki
Journal:  Biochem Pharmacol       Date:  2004-05-15       Impact factor: 5.858

9.  Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.

Authors:  Hideaki Nakaya; Barbara D Summers; Andrew C Nicholson; Antonio M Gotto; David P Hajjar; Jihong Han
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

Review 10.  Wnt signaling in cardiovascular physiology.

Authors:  K Marinou; C Christodoulides; C Antoniades; M Koutsilieris
Journal:  Trends Endocrinol Metab       Date:  2012-08-16       Impact factor: 12.015

View more
  39 in total

Review 1.  Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.

Authors:  Ma Eugenia Garay-Sevilla; Armando Gomez-Ojeda; Ileana González; Claudia Luévano-Contreras; Armando Rojas
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

Review 2.  Next Generation Risk Markers in Preventive Cardio-oncology.

Authors:  Morgan Lamberg; Andrea Rossman; Alexandra Bennett; Sabrina Painter; Rachel Goodman; James MacLeod; Ragasnehith Maddula; David Rayan; Krishna Doshi; Alexander Bick; Simone Bailey; Sherry-Ann Brown
Journal:  Curr Atheroscler Rep       Date:  2022-04-19       Impact factor: 5.113

Review 3.  Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.

Authors:  Anja Karlstaedt; Javid Moslehi; Rudolf A de Boer
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 32.419

4.  The role of genetic predisposition in cardiovascular risk after cancer diagnosis: a matched cohort study of the UK Biobank.

Authors:  Huazhen Yang; Yu Zeng; Wenwen Chen; Yajing Sun; Yao Hu; Zhiye Ying; Junren Wang; Yuanyuan Qu; Fang Fang; Unnur A Valdimarsdóttir; Huan Song
Journal:  Br J Cancer       Date:  2022-08-24       Impact factor: 9.075

Review 5.  Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Vivek Narayan; Elizabeth W Thompson; Biniyam Demissei; Jennifer E Ho; James L Januzzi; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2020-06-02       Impact factor: 24.094

6.  Glucose metabolism controls disease-specific signatures of macrophage effector functions.

Authors:  Ryu Watanabe; Marc Hilhorst; Hui Zhang; Markus Zeisbrich; Gerald J Berry; Barbara B Wallis; David G Harrison; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  JCI Insight       Date:  2018-10-18

Review 7.  Acquired and modifiable cardiovascular risk factors in patients treated for cancer.

Authors:  Gary S Beasley; Jeffrey A Towbin
Journal:  J Thromb Thrombolysis       Date:  2020-09-12       Impact factor: 2.300

8.  New Nanomaterials with Intrinsic Antioxidant Activity by Surface Functionalization of Niosomes with Natural Phenolic Acids.

Authors:  Elisabetta Mazzotta; Carla Orlando; Rita Muzzalupo
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

9.  Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.

Authors:  Bhupesh Singla; Hui-Ping Lin; Alex Chen; WonMo Ahn; Pushpankur Ghoshal; Mary Cherian-Shaw; Joseph White; Brian K Stansfield; Gábor Csányi
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

Review 10.  Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies.

Authors:  Gabriel Silva Marques Borges; Eduardo Burgarelli Lages; Pierre Sicard; Lucas Antônio Miranda Ferreira; Sylvain Richard
Journal:  Front Cardiovasc Med       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.